Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium Read more
Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001 Read more
Paratek Phase IIb data shows omadacycline’s potential to address unmet needs in NTM treatment, says GlobalData Read more
Lupin to focus on development of inhalers with near-zero global warming potential propellants Read more
